home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

A Potential New Drug Target To Restore Central Nervous System Function After Injury

  January, 19 2001 1:57
your information resource in human molecular genetics

Researchers at Yale University School of Medicine, New Haven, Connecticut, have identified a potential new target for drugs to restore function to the central nervous system after injury [Nature, Vol. 409, No. 6818, 18 Jan 2001, pp. 341–346]. Axons, the long arms of nerve cells, are essential for neuronal communication, but they do not regenerate after injury to the adult mammalian brain or spinal cord. This failure to regenerate is due in part to the production of a potent growth inhibitor, 'Nogo', by the cells that sheath axons in the insulating protein 'myelin'.

Stephen M. Strittmatter and colleagues have now found a high-affinity receptor for the extracellular domain of Nogo. This receptor provides the first insight into how Nogo acts. It is hoped that disrupting the interaction of Nogo with the new receptor may facilitate axonal regeneration in vivo.


Stephen M. Strittmatter
tel +1 203 785 4878
fax +1 203 785 5098
e-mail stephen.strittmatter@yale.edu

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.